AEON
AEON Biopharma, Inc.
NYSE MKT: AEON · HEALTHCARE · BIOTECHNOLOGY
$0.95
-3.02% today
Updated 2026-04-29
Market cap
$24.16M
P/E ratio
—
P/S ratio
97.16x
EPS (TTM)
$-3.95
Dividend yield
—
52W range
$0 – $1
Volume
0.1M
AEON Biopharma, Inc. (AEON) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-44.73M | $-9.46M | $-28.43M | $-35.58M | $-47.83M | $-20.29M | $-17.31M |
| Capital expenditures | $1.69M | $170000.00 | $170000.00 | $306000.00 | $0.00 | $0.00 | $4000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $5.25M | $4.79M | $5.22M | $5.89M | $7.10M | $6.25M | $5.32M |
| Free cash flow | $-46.42M | $-9.63M | $-28.60M | $-35.89M | $-47.83M | $-20.29M | $-17.31M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | $83.91M | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |